Trials / Unknown
UnknownNCT04995965
Infections With Enterobacteria Producing Carbapenemases at the University Hospitals of Strasbourg
Infections With Enterobacteria Producing Carbapenemases at the University Hospitals of Strasbourg - Descriptive Epidemiology and Risk Factors for Infection in the Event of Colonization
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 274 (estimated)
- Sponsor
- University Hospital, Strasbourg, France · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
Infections with enterobacteria producing carbapenemases at the University Hospitals of Strasbourg - descriptive epidemiology and risk factors for infection in the event of colonization There is a worrying situation of an increase in the number of patients colonized with carbapenemase-producing Enterobacteriaceae (CPE) at HUS. 7 to 15% of patients colonized with EPC would develop an infection with EPC. The cohorts published mainly concern patients hospitalized in intensive care. The associated mortality reported in the literature is high (\> 25%) and greater than that associated with infection with the same bacterium sensitive to carbapenems.
Conditions
Timeline
- Start date
- 2021-08-06
- Primary completion
- 2022-01-06
- Completion
- 2022-01-06
- First posted
- 2021-08-09
- Last updated
- 2021-08-09
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04995965. Inclusion in this directory is not an endorsement.